Namsa, a global medtech CRO has acquired CRI, a Germany-based full service CRO. The acquisition price is undisclosed. Namsa’s clinical research services include clinical study management, post market studies, biostatistics and…
Namsa, a global medtech CRO has acquired CRI, a Germany-based full service CRO. The acquisition price is undisclosed. Namsa’s clinical research services include clinical study management, post market studies, biostatistics and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


